Alnylam Pharmaceuticals
ALNY
#847
Rank
A$43.17 B
Marketcap
A$322.65
Share price
0.67%
Change (1 day)
-53.22%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company